Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply.

Nguyen, Thuy D; Saloner, Brendan; Stein, Bradley D

Nguyen, Thuy D; Saloner, Brendan; Stein, Bradley D.

Nguyen TD; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor.
Saloner B; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Stein BD; RAND Corporation, Pittsburgh, Pennsylvania.

JAMA Intern Med ; 181(8): 1135-1136, 2021 08 01.

Article in English | MEDLINE | ID: covidwho-1554432

Subject(s)

Buprenorphine; COVID-19; Opioid-Related Disorders; Analgesics, Opioid/therapeutic use; Buprenorphine/therapeutic use; Humans; Opiate Substitution Treatment; Opioid-Related Disorders/drug therapy; Opioid-Related Disorders/epidemiology; Opioid-Related Disorders/prevention & control; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Language: English Journal: JAMA Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google